Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Optical Cable Co. stock logo
OCC
Optical Cable
$2.82
+1.1%
$3.27
$2.02
$7.00
$23.12M0.29181,253 shs6,641 shs
PureTech Health plc stock logo
PRTC
PureTech Health
$17.26
+0.7%
$17.48
$13.30
$32.98
$414.57M1.124,675 shs2,828 shs
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
$10.02
+0.4%
$0.00
$5.83
$26.25
$418.83MN/A194,838 shs79,751 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Optical Cable Co. stock logo
OCC
Optical Cable
0.00%-1.81%-4.08%-45.45%-5.88%
PureTech Health plc stock logo
PRTC
PureTech Health
0.00%+1.95%-10.75%-7.30%-39.44%
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
0.00%+12.33%+22.64%+1,001,999,900.00%+1,001,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Optical Cable Co. stock logo
OCC
Optical Cable
0.4913 of 5 stars
0.03.00.00.01.81.70.0
PureTech Health plc stock logo
PRTC
PureTech Health
2.0142 of 5 stars
3.83.00.00.02.70.00.0
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Optical Cable Co. stock logo
OCC
Optical Cable
0.00
N/AN/AN/A
PureTech Health plc stock logo
PRTC
PureTech Health
3.50
Strong Buy$45.00160.72% Upside
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
3.00
Buy$40.00299.20% Upside

Current Analyst Ratings Breakdown

Latest RCE, ZBIO, PRTC, and OCC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/20/2025
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$35.00
3/12/2025
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$45.00 ➝ $45.00
(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Optical Cable Co. stock logo
OCC
Optical Cable
$67.56M0.34N/AN/A$2.54 per share1.11
PureTech Health plc stock logo
PRTC
PureTech Health
$3.33M124.49N/AN/A$16.94 per share1.02
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
$5M83.77N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Optical Cable Co. stock logo
OCC
Optical Cable
-$4.21M-$0.50N/AN/A-6.31%-19.50%-10.64%6/9/2025 (Estimated)
PureTech Health plc stock logo
PRTC
PureTech Health
-$65.70MN/A0.00N/AN/AN/AN/AN/AN/A
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
N/A-$3.55N/AN/AN/AN/AN/AN/A

Latest RCE, ZBIO, PRTC, and OCC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/10/2025Q1 2025
Optical Cable Co. stock logo
OCC
Optical Cable
N/A-$0.14N/A-$0.14N/A$15.74 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Optical Cable Co. stock logo
OCC
Optical Cable
$0.082.84%N/AN/A N/A
PureTech Health plc stock logo
PRTC
PureTech Health
N/AN/AN/AN/AN/A
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
$0.050.48%N/AN/A N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Optical Cable Co. stock logo
OCC
Optical Cable
0.52
4.49
1.74
PureTech Health plc stock logo
PRTC
PureTech Health
N/A
3.68
N/A
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Optical Cable Co. stock logo
OCC
Optical Cable
13.61%
PureTech Health plc stock logo
PRTC
PureTech Health
0.04%
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
N/A

Insider Ownership

CompanyInsider Ownership
Optical Cable Co. stock logo
OCC
Optical Cable
23.80%
PureTech Health plc stock logo
PRTC
PureTech Health
5.30%
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Optical Cable Co. stock logo
OCC
Optical Cable
3408.20 million6.33 millionNot Optionable
PureTech Health plc stock logo
PRTC
PureTech Health
10024.02 million22.67 millionNot Optionable
Zenas Biopharma Inc stock logo
ZBIO
Zenas Biopharma
N/A41.80 millionN/AN/A

Recent News About These Companies

Head-To-Head Contrast: Zenas Biopharma (ZBIO) vs. Its Competitors
Reviewing Zenas Biopharma (ZBIO) & The Competition

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Optical Cable stock logo

Optical Cable NASDAQ:OCC

$2.82 +0.03 (+1.08%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$2.79 -0.03 (-1.03%)
As of 04/25/2025 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Optical Cable Corporation, together with its subsidiaries, engages in the manufacture and sale of fiber optic and copper data communications cabling and connectivity solutions primarily for the enterprise market in the United States and internationally. The company provides fiber optic and hybrid cables for high bandwidth transmission of data, video, and voice communications; and copper datacom cables, including unshielded and shielded twisted pair constructions. Its fiber optic connectivity products include fiber optic wall mounts, cabinet mount and rack mount enclosures, pre-terminated fiber optic enclosures, fiber optic connectors, splice trays, fiber optic jumpers, plug and play cassette modules, pre-terminated fiber optic cable assemblies, adapters, and accessories; and copper connectivity products comprising category compliant patch panels, jacks, plugs, patch cords, faceplates, surface mounted boxes, distribution and multi-media boxes, copper rack mount and wall mount enclosures, cable assemblies, cable organizers, and other wiring products for equipment rooms, telecommunications closets, data centers, and workstation applications. In addition, the company offers network, data storage, and telecommunications management systems, such as data cabinets, wall mount enclosures, horizontal and vertical cable management systems, and open frame relay racks; and datacom wiring products, including various enclosures, and modules and modular outlets for single dwelling and multiple dwelling residential uses. Further, it provides specialty fiber optic connectors and connectivity components, copper datacom connectors, and related systems and solutions for military, other harsh environment, and special applications, as well as cylindrical connector products. The company sells its products to distributors, original equipment manufacturers, value-added resellers, and end-users. Optical Cable Corporation was incorporated in 1983 and is headquartered in Roanoke, Virginia.

PureTech Health stock logo

PureTech Health NASDAQ:PRTC

$17.26 +0.12 (+0.70%)
Closing price 04/25/2025 03:57 PM Eastern
Extended Trading
$17.27 +0.01 (+0.09%)
As of 04/25/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Zenas Biopharma stock logo

Zenas Biopharma NASDAQ:ZBIO

$10.02 +0.04 (+0.40%)
As of 04/25/2025 04:00 PM Eastern

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.